CAS RN: 2145122-45-6
Cyclopenta[d]-1,2,3-oxathiazole-3(3aH)-carboxylic acid, tetrahydro-, 1,1-dimethylethyl ester, 2,2-dioxide, (3aS,6aR)-
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250330
50mg
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 2145122-45-6
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥95%
0
Out of Stock
Beijing
Inquiry
2145122-45-6 / tert-butyl (3aS,6aR)-2,2-dioxo-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]oxathiazole-3-carboxylate
Standard CAS: 2145122-45-6
Multi CAS: No
Basic Information
copy
CAS
2145122-45-6 copy
Multi CAS
No copy
Molecular Formula
C10H17NO5S copy
Molecular Weight
263.310000 copy
Exact Mass
263.082744 copy
SMILES
CC(C)(C)OC(=O)N1[C@H]2CCC[C@H]2OS1(=O)=O copy
InChI
InChI=1S/C10H17NO5S/c1-10(2,3)15-9(12)11-7-5-4-6-8(7)16-17(11,13)14/h7-8H,4-6H2,1-3H3/t7-,8+/m0/s1 copy
InChIKey
ZNCCYXVZFSELKH-JGVFFNPUSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
17 copy
Fraction Csp3
0.9 copy
Rotatable bonds
2 copy
H-bond acceptors
5 copy
Molar refractivity
59.5 copy
TPSA
72.91 copy
LogP / Solubility
WLOGP
1.42 copy
MLOGP
1.26 copy
XLogP3
1.5 copy
Consensus LogP
1.39 copy
Log S (ESOL)
-2.37 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.74 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.55 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.32 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
2.5 copy